SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19Nina Kreuzberger, Nicole Skoetz, David J. Roberts et al.|Cochrane Database of Systematic Reviews|2021Cited by 152
Persistence of immunoglobulin G after natural infection with SARS-CoV-2Nina Kreuzberger, Nicole Skoetz, Caroline Hirsch et al.|Cochrane Database of Systematic Reviews|2021Cited by 0
Risk of bias assessments for the Cochrane review 'SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19'Nina Kreuzberger, Nicole Skoetz, Caroline Hirsch et al.|Zenodo (CERN European Organization for Nuclear Research)|2021Cited by 0
Risk of bias assessments for the Cochrane review 'SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19'Nina Kreuzberger, Nicole Skoetz, Caroline Hirsch et al.|Zenodo (CERN European Organization for Nuclear Research)|2021Cited by 0
Risk of bias assessments for the Cochrane review 'SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19'Nina Kreuzberger, Nicole Skoetz, Caroline Hirsch et al.|Figshare|2021Cited by 0